17 Jul 2020 09:15
Instem plc("Instem" or the "Company")
Director/PDMR Dealings
Instem (AIM: INS.L), a leading provider of IT solutions to the global life sciences market, confirms the following dealings in Ordinary Shares by certain of the Company's Directors (each of whom is a PDMR) and, where relevant, their PCAs as outlined below. These dealings are further to the Company's announcement made on 26 June 2020 regarding the proposed Placing which completed this morning:
Director/PDMR | No. of Ordinary Shares held prior to the Placing | No. of options over Ordinary Shares exercised | No. of Ordinary Shares sold in the Placing | Resulting number of Ordinary Shares | As a % of Enlarged Share Capital |
David Gare and his wife (via the DG 2008 Discretionary Settlement) | 578,427 | - | (40,000) | 538,427 | 2.6% |
Phil Reason | 685,287 | 187,427 | (142,000) | 730,714 | 3.6% |
David Sherwin | 1,180,066 | - | (430,066) | 750,000 | 3.7% |
Capitalised terms used in this announcement shall, unless defined in this announcement or unless the context provides otherwise, bear the same meaning ascribed to such terms in the in the Circular and Notice of General Meeting dated 30 June 2020, a copy of which is available to view on the Company's website at https://investors.instem.com/news/articles/0620-publication-of-circular.php.
For further information, please contact:
Instem plc | +44 (0) 1785 825 600 |
Phil Reason, CEO | |
Nigel Goldsmith, CFO | |
N+1 Singer (Nominated Adviser & Broker) |
+44 (0) 20 7496 3000 |
Peter Steel Rachel Hayes | |
Walbrook Financial PR |
+44 (0) 20 7933 8780 |
Tom Cooper | instem@walbrookpr.com |
Nick Rome
|
About Instem
Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.
Instem solutions are in use by over 500 customers worldwide, including all the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster. Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem products and services now address aspects of the entire drug development value chain, from discovery through to market launch. Management estimate that over 50% of all drugs on the market have been through some part of Instem's platform at some stage of their development.
To learn more about Instem solutions and its mission, please visit www.instem.com.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||
a) | Name | David Gare and his wife (via the DG 2008 Discretionary Settlement) | |
2 | Reason for the notification | ||
a) | Position/status | Non-Executive Chairman | |
b) | Initial notification /Amendment | Initial Notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Instem plc | |
b) | LEI | 213800PILYUFNNROQX68 | |
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 10 pence each
GB00B3TQCK30 | |
b) | Nature of the transaction | Sale of ordinary shares | |
c)
| Price(s) and volume(s)
| Price | Volume |
435 pence | 40,000 | ||
d)
| Aggregated information
- Aggregated volume
- Price
| N/A - single transaction | |
e) | Date of the transaction | 17 July 2020 | |
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | |
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||
a) | Name | Phil Reason | |
2 | Reason for the notification | ||
a) | Position/status | Chief Executive Officer | |
b) | Initial notification /Amendment | Initial Notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Instem plc | |
b) | LEI | 213800PILYUFNNROQX68 | |
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 10 pence each
GB00B3TQCK30 | |
b) | Nature of the transaction | 1. Exercise of options over Ordinary Shares 2. Sale of Ordinary Shares | |
c)
| Price(s) and volume(s)
| Price | Volume |
1. 175 pence 2. 435 pence | 1. 187,427 2. 142,000 | ||
d)
| Aggregated information
- Aggregated volume
- Price
| n/a - the exercise of options over Ordinary Shares and the sale of Ordinary Shares each completed as single transactions | |
e) | Date of the transaction | 17 July 2020 | |
f) | Place of the transaction | In respect of the exercise of options over Ordinary Shares: outside a trading venue In respect of the sale of Ordinary Shares: London Stock Exchange, AIM Market (XLON) | |
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||
a) | Name | David Sherwin | |
2 | Reason for the notification | ||
a) | Position/status | Non-Executive Director | |
b) | Initial notification /Amendment | Initial Notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Instem plc | |
b) | LEI | 213800PILYUFNNROQX68 | |
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 10 pence each
GB00B3TQCK30 | |
b) | Nature of the transaction | Sale of Ordinary Shares | |
c)
| Price(s) and volume(s)
| Price | Volume |
435 pence | 430,066 | ||
d)
| Aggregated information
- Aggregated volume
- Price | N/A - single transaction | |
e) | Date of the transaction | 17 July 2020 | |
f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | |
Name of authorised official of issuer responsible for making notification:
Nigel Goldsmith
Company Secretary to Instem plc